focus today
[ Will Semiconductor Co.Ltd.Shanghai(603501) : wholly owned enterprise plans to increase its holdings of Ingenic Semiconductor Co.Ltd(300223) shares by no more than 4 billion yuan]
Will Semiconductor Co.Ltd.Shanghai(603501) announced that Shaoxing Weihao, a wholly-owned enterprise, plans to increase its Ingenic Semiconductor Co.Ltd(300223) shares by no more than 4 billion yuan, and the cumulative number of Ingenic Semiconductor Co.Ltd(300223) shares held after the increase is no more than 50 million shares, no more than 10.38% of the total share capital.
[ Tianqi Lithium Corporation(002466) : the net profit of sqm in the first quarter was 796 million USD]
The company’s net profit in the first half of the year is expected to exceed sqm’s total net profit of $4.626 billion, which is expected to increase by about $2.022 billion in the first half of the year.
[ Sansure Biotech Inc(688289) : three test products have obtained EU CE list a certification]
Sansure Biotech Inc(688289) announced that the company’s products hepatitis B virus nucleic acid detection kit (PCR fluorescence method), hepatitis C virus nucleic acid detection kit (PCR fluorescence method) and human immunodeficiency virus type 1 nucleic acid determination kit (PCR fluorescence probe method) have recently obtained EU CE certification (IVDD list class a).
[ Tbea Co.Ltd(600089) : Xingtang 200MW photovoltaic project has been shut down and relevant investigation has not been completed]
Tbea Co.Ltd(600089) announced that the company is concerned about the media reports on the photovoltaic power generation project of Xingtang company, the fourth level subsidiary of the company. The description is as follows: Xingtang 200MW photovoltaic project is invested and constructed by Xingtang company, a four level subsidiary of the company. During the promotion of Xingtang 200MW photovoltaic project, there are some problems, such as inadequate mass work, non-standard contract signing procedures, lack of supervision, construction violations and other problems. At present, the construction of the project has been stopped. Relevant departments have filed an investigation on the crime of suspected sabotage of production and operation during the construction of Xingtang company, and taken compulsory measures of criminal detention for the project leader according to law, but the relevant investigation has not been completed. Xingtang 200MW photovoltaic project is still in the early stage of project construction, with less capital investment. This event has little impact on the operation of the company.
fixed increase & Financing & repurchase
[ Meihua Holdings Group Co.Ltd(600873) : plan to spend 800 million to 1 billion yuan to buy back the company’s shares]
Meihua Holdings Group Co.Ltd(600873) announced that the company plans to repurchase the company’s shares with its own funds with a total amount of not less than 800 million yuan (inclusive) and not more than 1 billion yuan (inclusive), and the repurchased shares will be used for cancellation and reduce the registered capital, and the repurchase price will not exceed 12 yuan / share.
reduction & increase
[ Zhejiang Provincial New Energy Investment Group Co.Ltd(600032) : proposed reduction of no more than 35299600 shares Qianjiang Water Resources Development Co; Ltd(600283) shares]
Zhejiang Provincial New Energy Investment Group Co.Ltd(600032) announced that it is proposed to reduce the holding of no more than 352996 million Qianjiang Water Resources Development Co; Ltd(600283) shares at the right time, accounting for no more than 10% of Qianjiang Water Resources Development Co; Ltd(600283) total share capital, and the implementation period is the fiscal year from the date of approval by the board of directors of the company.
[ {{{{{{{{{{{{
Guangdong Marubi Biotechnology Co.Ltd(603983) announced that the shareholder l capital reduced 1.72% of the shares of the company through block trading, and the shareholding ratio decreased to less than 5.
[ China Pacific Insurance (Group) Co.Ltd(601601) : Shanghai state owned assets and persons acting in concert increase 1% shares of the company]
China Pacific Insurance (Group) Co.Ltd(601601) announcement: Shanghai state owned assets and persons acting in concert increased their shareholding by 1% from April 9 to May 20, with a shareholding ratio of 10.32%.
[ Allgens Medical Technology Co.Ltd(688613) : three shareholders plan to reduce the total shares of the company by no more than 10.56%]
Allgens Medical Technology Co.Ltd(688613) announced that the shareholders Qilun Tianyou, bioveda and Jiaxinghua control plan to reduce the total shares of the company by no more than 10.56%.
Nanjing Shenghang Shipping Co.Ltd(001205) Nanjing Shenghang Shipping Co.Ltd(001205) : the the Belt and Road fund plans to reduce its shareholding of the company by no more than 5%
Nanjing Shenghang Shipping Co.Ltd(001205) .
transfer and acquisition & Investment
[ Shanghai Sk Automation Technology Co.Ltd(688155) : proposed to purchase 51% equity of Ningde Dongheng with RMB 816 million]
Shanghai Sk Automation Technology Co.Ltd(688155) announced that it plans to pay cash to purchase 51% equity of Ningde Dongheng, with a total transaction amount of 816 million yuan. After the completion of this transaction, the company will become its controlling shareholder and expand its business from the field of new energy battery production line to the field of new energy battery parts.
[ Jiangxi Jovo Energy Co.Ltd(605090) : proposed to purchase 100% shares of Sentai energy]
Jiangxi Jovo Energy Co.Ltd(605090) announced that it plans to purchase 100% shares of Sentai energy with a transaction consideration of 1.8 billion yuan; The company plans to pay 600 million yuan in cash, 120 million yuan in shares and 1.08 billion yuan in convertible bonds. After the “land gas + Sea gas” transaction of the company is completed, the “land gas + Sea gas” pattern will be formed.
[ Shenzhen Woer Heat-Shrinkable Material Co.Ltd(002130) : signing framework agreement with Hongshan District People’s Government of Wuhan city]
Shenzhen Woer Heat-Shrinkable Material Co.Ltd(002130) announced that the company has signed a framework agreement with the people’s Government of Hongshan District, Wuhan, and plans to invest no less than 500 million yuan in the construction of Shenzhen Woer Heat-Shrinkable Material Co.Ltd(002130) new materials Industrial Park to carry out the production and R & D of radiation modified new materials, electronic and power products, high-speed communication lines, automobile industrial lines and other products.
[ Nan Jing Xin Jie Kou Department Store Co.Ltd(600682) : the subsidiary plans to purchase 2 million shares of the international umbilical cord blood bank with us $13 million]
Nan Jing Xin Jie Kou Department Store Co.Ltd(600682) announced that the subsidiary dendreon plans to purchase 2 million shares of the international umbilical cord blood bank for us $13 million, which will help expand the company’s business in the storage and application of umbilical cord blood hematopoietic stem cells and improve the company’s competitiveness.
[ Silvery Dragon Prestressed Materials Co.Ltd Tianjin(603969) : signing steel strand procurement contract with CCCC Third Navigation Bureau]
Silvery Dragon Prestressed Materials Co.Ltd Tianjin(603969) announced that the purchase contract of steel strand signed by the company and Engineering Materials Co., Ltd. of CCCC Third Navigation Bureau is a sales contract of prestressed steel strand with a contract amount of 218 million yuan.
approved & awarded
[ Shenzhen Zhongzhuang Construction Group Co.Ltd(002822) : winning a number of major projects in succession, with a total winning amount of 505 million yuan]
Shenzhen Zhongzhuang Construction Group Co.Ltd(002822) announcement: Recently, the company successively won a number of major engineering projects, with a total winning amount of RMB 505 million.
[ Hainan Poly Pharm.Co.Ltd(300630) : iopanol injection is approved by the Dutch drug evaluation committee]
Hainan Poly Pharm.Co.Ltd(300630) announced that the company’s iodopatol injection was approved by the Dutch drug evaluation committee for listing.
[ Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) : the first subject enrolled in the phase I clinical trial of the subsidiary’s class I innovative drug ray1216 tablets]
Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) announcement: Recently, Zhongsheng RuiChuang, a holding subsidiary of the company, has obtained the consent of the ethics committee of the first hospital of Jilin University for the phase I clinical trial of oral anti novel coronavirus 3CL protease inhibitor ray1216 tablets, and completed the enrollment of the first subject.
others
[long term retirement: the company’s shares will be delisted on May 23] long term retirement announcement: the delisting period of the company’s shares ends and will be delisted on May 23.
